CN Stock MarketDetailed Quotes

Hangzhou Alltest Biotech (688606)

Watchlist
  • 54.84
  • -0.74-1.33%
Market Closed May 14 15:00 CST
4.35BMarket Cap24.37P/E (TTM)

Hangzhou Alltest Biotech (688606) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
-6.29%195.37M
4.47%905.34M
2.44%633.08M
8.41%429.85M
4.28%208.48M
14.83%866.58M
10.37%618.03M
2.23%396.5M
-15.34%199.92M
-77.73%754.7M
Operating revenue
-6.29%195.37M
4.47%905.34M
2.44%633.08M
8.41%429.85M
4.28%208.48M
14.83%866.58M
10.37%618.03M
2.23%396.5M
-15.34%199.92M
-77.73%754.7M
Total operating cost
24.36%178.18M
24.41%711.57M
7.65%457.64M
9.59%299.11M
-0.60%143.28M
-3.40%571.94M
-2.91%425.1M
-10.78%272.93M
-19.44%144.14M
-66.17%592.08M
Operating cost
-0.55%91.99M
15.73%444.09M
1.38%277.21M
4.78%186.93M
-7.22%92.5M
-0.72%383.74M
-6.25%273.43M
-13.86%178.39M
-10.73%99.7M
-71.53%386.54M
Operating tax surcharges
107.65%6.09M
-0.20%9.55M
-8.27%4.38M
12.87%4.04M
43.13%2.93M
35.93%9.57M
28.96%4.77M
37.89%3.58M
28.80%2.05M
-74.71%7.04M
Operating expense
19.87%16.79M
43.20%79.32M
43.00%59.9M
27.92%38.44M
29.55%14.01M
-20.06%55.39M
-11.72%41.89M
-7.95%30.05M
-35.15%10.81M
-53.91%69.29M
Administration expense
30.78%19.68M
22.99%79.75M
19.00%54.31M
14.83%34.61M
11.52%15.05M
-2.62%64.84M
-5.81%45.64M
-12.56%30.14M
-25.74%13.49M
-14.70%66.59M
Financial expense
729.26%14.88M
72.09%-10.45M
-2.03%-12.37M
28.79%-13.09M
53.42%-2.37M
36.06%-37.43M
71.87%-12.13M
50.00%-18.39M
4.59%-5.08M
17.47%-58.54M
-Interest expense (Financial expense)
269.92%206.8K
-32.50%280.38K
-38.63%224.73K
-61.57%100.23K
-57.83%55.9K
-71.53%415.35K
-68.65%366.18K
-68.71%260.84K
-70.04%132.56K
-32.80%1.46M
-Interest Income (Financial expense)
-97.07%-4.48M
23.82%-25.49M
-0.81%-18M
24.24%-13.24M
57.67%-2.27M
26.56%-33.47M
39.44%-17.86M
19.82%-17.48M
36.50%-5.37M
-6.26%-45.57M
Research and development
35.91%28.75M
14.08%109.32M
3.79%74.22M
-1.96%48.2M
-8.66%21.15M
-20.92%95.82M
-20.28%71.5M
-25.38%49.16M
-35.89%23.16M
-41.55%121.17M
Credit Impairment Loss
26.24%-3.32M
59.23%-3.18M
47.99%-7.25M
59.25%-5M
60.42%-4.5M
30.61%-7.79M
1.21%-13.94M
-13.89%-12.26M
-45.58%-11.37M
-102.06%-11.23M
Asset Impairment Loss
49.45%-50.6K
53.02%-4.26M
91.69%-608.01K
92.75%-608.01K
98.16%-100.1K
-261.96%-9.07M
-793.52%-7.31M
-275.45%-8.39M
68.09%-5.44M
102.00%5.6M
Other net revenue
Fair value change income
167.40%5.62M
14.24%40.61M
-15.92%18.96M
25.02%15.82M
-37.53%2.1M
8.82%35.55M
354.49%22.55M
797.97%12.66M
-64.70%3.36M
314.66%32.67M
Invest income
40.34%726.24K
-97.25%335.65K
-23.80%8.83M
-33.91%6.08M
-87.69%517.48K
41.23%12.19M
82.70%11.59M
46.95%9.21M
-9.77%4.2M
-64.20%8.63M
-Including: Investment income associates
----
-505.07%-2.87M
----
----
----
---474.89K
----
----
----
----
Asset deal income
--65.04K
-49.65%616.68K
-82.28%616.68K
----
----
392.14%1.22M
750.33%3.48M
724.52%3.34M
99.28%-6.08K
-178.63%-419.22K
Other revenue
4.03%1.41M
27.42%23.91M
30.44%22.82M
-60.21%5.54M
70.35%1.36M
36.88%18.77M
88.04%17.49M
74.27%13.92M
38.25%796.95K
-56.82%13.71M
Operating profit
-66.48%21.64M
-27.12%251.81M
-3.52%218.81M
7.41%152.58M
36.44%64.57M
63.30%345.52M
75.66%226.78M
55.97%142.05M
2.32%47.33M
-84.82%211.58M
Add:Non operating Income
--172.12K
-99.99%452.66
-99.85%277.3
-100.00%0.3
----
13,131.01%3.19M
1,186.68%179.81K
1,186.18%179.74K
11,774.39%100K
-80.76%24.08K
Less:Non operating expense
1.66%55.87K
-36.03%633.88K
-84.56%562.89K
-84.63%473.49K
-79.77%54.96K
-93.01%990.91K
-74.25%3.64M
-77.72%3.08M
35.77%271.7K
13.29%14.17M
Total profit
-66.27%21.76M
-27.76%251.18M
-2.27%218.25M
9.31%152.11M
36.82%64.52M
76.11%347.71M
94.25%223.32M
80.10%139.15M
2.39%47.16M
-85.71%197.44M
Less:Income tax cost
-21.31%2.63M
-30.58%31.1M
10.67%28.52M
28.13%20.01M
32.94%3.34M
161.12%44.8M
87.89%25.77M
142.62%15.61M
-56.06%2.51M
-91.25%17.16M
Net profit
-68.73%19.13M
-27.35%220.07M
-3.96%189.72M
6.94%132.1M
37.04%61.18M
68.02%302.91M
95.11%197.55M
74.42%123.53M
10.68%44.64M
-84.79%180.28M
Net profit from continuing operation
-68.73%19.13M
-27.35%220.07M
-3.96%189.72M
6.94%132.1M
37.04%61.18M
68.02%302.91M
95.11%197.55M
74.42%123.53M
10.68%44.64M
-84.79%180.28M
Less:Minority Profit
-606.59%-263.36K
-127.40%-119.99K
-561.55%-86.57K
125.84%89.11K
74.22%-37.27K
248.14%437.87K
105.87%18.76K
2.86%-344.83K
26.37%-144.58K
-154.94%-295.58K
Net profit of parent company owners
-68.32%19.39M
-27.20%220.19M
-3.91%189.81M
6.57%132.01M
36.68%61.22M
67.50%302.47M
94.48%197.53M
74.03%123.88M
10.50%44.79M
-84.76%180.58M
Earning per share
Basic earning per share
-68.83%0.24
-27.23%2.78
-4.02%2.39
7.05%1.67
37.50%0.77
67.54%3.82
94.53%2.49
73.33%1.56
9.80%0.56
-84.75%2.28
Diluted earning per share
-68.83%0.24
-27.23%2.78
-4.02%2.39
7.05%1.67
37.50%0.77
67.54%3.82
94.53%2.49
73.33%1.56
9.80%0.56
-84.75%2.28
Other composite income
211.34%308.04K
-120.51%-361.48K
58.80%-608.94K
-199.82%-647.35K
-282.80%-276.67K
-25.57%1.76M
-138.06%-1.48M
-86.37%648.53K
153.93%151.35K
-91.58%2.37M
Other composite income of parent company owners
209.83%301.1K
-118.92%-330.3K
58.72%-610.33K
-201.07%-644.84K
-289.59%-274.16K
-26.12%1.75M
-138.09%-1.48M
-86.58%637.99K
142.57%144.61K
-91.60%2.36M
Other composite income of minority owners
376.76%6.94K
-291.55%-31.17K
386.93%1.39K
-123.78%-2.51K
-137.19%-2.51K
262.01%16.27K
-89.24%285.66
149.32%10.55K
-88.58%6.74K
180.83%4.5K
Total composite income
-68.08%19.44M
-27.89%219.71M
-3.55%189.11M
5.86%131.45M
35.96%60.9M
66.81%304.67M
86.50%196.07M
64.30%124.18M
11.83%44.8M
-84.95%182.65M
Total composite income of parent company owners
-67.68%19.7M
-27.73%219.86M
-3.49%189.2M
5.50%131.37M
35.63%60.94M
66.29%304.22M
85.92%196.05M
63.98%124.52M
11.79%44.93M
-84.92%182.94M
Total composite income of minority owners
-544.59%-256.42K
-133.29%-151.17K
-547.32%-85.18K
125.91%86.6K
71.14%-39.78K
256.02%454.15K
106.01%19.04K
4.70%-334.28K
-0.37%-137.84K
-154.67%-291.09K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
--
--
Unqualified opinion
Auditor
--
--
--
--
--
--
--
--
--
PwC China (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue -6.29%195.37M4.47%905.34M2.44%633.08M8.41%429.85M4.28%208.48M14.83%866.58M10.37%618.03M2.23%396.5M-15.34%199.92M-77.73%754.7M
Operating revenue -6.29%195.37M4.47%905.34M2.44%633.08M8.41%429.85M4.28%208.48M14.83%866.58M10.37%618.03M2.23%396.5M-15.34%199.92M-77.73%754.7M
Total operating cost 24.36%178.18M24.41%711.57M7.65%457.64M9.59%299.11M-0.60%143.28M-3.40%571.94M-2.91%425.1M-10.78%272.93M-19.44%144.14M-66.17%592.08M
Operating cost -0.55%91.99M15.73%444.09M1.38%277.21M4.78%186.93M-7.22%92.5M-0.72%383.74M-6.25%273.43M-13.86%178.39M-10.73%99.7M-71.53%386.54M
Operating tax surcharges 107.65%6.09M-0.20%9.55M-8.27%4.38M12.87%4.04M43.13%2.93M35.93%9.57M28.96%4.77M37.89%3.58M28.80%2.05M-74.71%7.04M
Operating expense 19.87%16.79M43.20%79.32M43.00%59.9M27.92%38.44M29.55%14.01M-20.06%55.39M-11.72%41.89M-7.95%30.05M-35.15%10.81M-53.91%69.29M
Administration expense 30.78%19.68M22.99%79.75M19.00%54.31M14.83%34.61M11.52%15.05M-2.62%64.84M-5.81%45.64M-12.56%30.14M-25.74%13.49M-14.70%66.59M
Financial expense 729.26%14.88M72.09%-10.45M-2.03%-12.37M28.79%-13.09M53.42%-2.37M36.06%-37.43M71.87%-12.13M50.00%-18.39M4.59%-5.08M17.47%-58.54M
-Interest expense (Financial expense) 269.92%206.8K-32.50%280.38K-38.63%224.73K-61.57%100.23K-57.83%55.9K-71.53%415.35K-68.65%366.18K-68.71%260.84K-70.04%132.56K-32.80%1.46M
-Interest Income (Financial expense) -97.07%-4.48M23.82%-25.49M-0.81%-18M24.24%-13.24M57.67%-2.27M26.56%-33.47M39.44%-17.86M19.82%-17.48M36.50%-5.37M-6.26%-45.57M
Research and development 35.91%28.75M14.08%109.32M3.79%74.22M-1.96%48.2M-8.66%21.15M-20.92%95.82M-20.28%71.5M-25.38%49.16M-35.89%23.16M-41.55%121.17M
Credit Impairment Loss 26.24%-3.32M59.23%-3.18M47.99%-7.25M59.25%-5M60.42%-4.5M30.61%-7.79M1.21%-13.94M-13.89%-12.26M-45.58%-11.37M-102.06%-11.23M
Asset Impairment Loss 49.45%-50.6K53.02%-4.26M91.69%-608.01K92.75%-608.01K98.16%-100.1K-261.96%-9.07M-793.52%-7.31M-275.45%-8.39M68.09%-5.44M102.00%5.6M
Other net revenue
Fair value change income 167.40%5.62M14.24%40.61M-15.92%18.96M25.02%15.82M-37.53%2.1M8.82%35.55M354.49%22.55M797.97%12.66M-64.70%3.36M314.66%32.67M
Invest income 40.34%726.24K-97.25%335.65K-23.80%8.83M-33.91%6.08M-87.69%517.48K41.23%12.19M82.70%11.59M46.95%9.21M-9.77%4.2M-64.20%8.63M
-Including: Investment income associates -----505.07%-2.87M---------------474.89K----------------
Asset deal income --65.04K-49.65%616.68K-82.28%616.68K--------392.14%1.22M750.33%3.48M724.52%3.34M99.28%-6.08K-178.63%-419.22K
Other revenue 4.03%1.41M27.42%23.91M30.44%22.82M-60.21%5.54M70.35%1.36M36.88%18.77M88.04%17.49M74.27%13.92M38.25%796.95K-56.82%13.71M
Operating profit -66.48%21.64M-27.12%251.81M-3.52%218.81M7.41%152.58M36.44%64.57M63.30%345.52M75.66%226.78M55.97%142.05M2.32%47.33M-84.82%211.58M
Add:Non operating Income --172.12K-99.99%452.66-99.85%277.3-100.00%0.3----13,131.01%3.19M1,186.68%179.81K1,186.18%179.74K11,774.39%100K-80.76%24.08K
Less:Non operating expense 1.66%55.87K-36.03%633.88K-84.56%562.89K-84.63%473.49K-79.77%54.96K-93.01%990.91K-74.25%3.64M-77.72%3.08M35.77%271.7K13.29%14.17M
Total profit -66.27%21.76M-27.76%251.18M-2.27%218.25M9.31%152.11M36.82%64.52M76.11%347.71M94.25%223.32M80.10%139.15M2.39%47.16M-85.71%197.44M
Less:Income tax cost -21.31%2.63M-30.58%31.1M10.67%28.52M28.13%20.01M32.94%3.34M161.12%44.8M87.89%25.77M142.62%15.61M-56.06%2.51M-91.25%17.16M
Net profit -68.73%19.13M-27.35%220.07M-3.96%189.72M6.94%132.1M37.04%61.18M68.02%302.91M95.11%197.55M74.42%123.53M10.68%44.64M-84.79%180.28M
Net profit from continuing operation -68.73%19.13M-27.35%220.07M-3.96%189.72M6.94%132.1M37.04%61.18M68.02%302.91M95.11%197.55M74.42%123.53M10.68%44.64M-84.79%180.28M
Less:Minority Profit -606.59%-263.36K-127.40%-119.99K-561.55%-86.57K125.84%89.11K74.22%-37.27K248.14%437.87K105.87%18.76K2.86%-344.83K26.37%-144.58K-154.94%-295.58K
Net profit of parent company owners -68.32%19.39M-27.20%220.19M-3.91%189.81M6.57%132.01M36.68%61.22M67.50%302.47M94.48%197.53M74.03%123.88M10.50%44.79M-84.76%180.58M
Earning per share
Basic earning per share -68.83%0.24-27.23%2.78-4.02%2.397.05%1.6737.50%0.7767.54%3.8294.53%2.4973.33%1.569.80%0.56-84.75%2.28
Diluted earning per share -68.83%0.24-27.23%2.78-4.02%2.397.05%1.6737.50%0.7767.54%3.8294.53%2.4973.33%1.569.80%0.56-84.75%2.28
Other composite income 211.34%308.04K-120.51%-361.48K58.80%-608.94K-199.82%-647.35K-282.80%-276.67K-25.57%1.76M-138.06%-1.48M-86.37%648.53K153.93%151.35K-91.58%2.37M
Other composite income of parent company owners 209.83%301.1K-118.92%-330.3K58.72%-610.33K-201.07%-644.84K-289.59%-274.16K-26.12%1.75M-138.09%-1.48M-86.58%637.99K142.57%144.61K-91.60%2.36M
Other composite income of minority owners 376.76%6.94K-291.55%-31.17K386.93%1.39K-123.78%-2.51K-137.19%-2.51K262.01%16.27K-89.24%285.66149.32%10.55K-88.58%6.74K180.83%4.5K
Total composite income -68.08%19.44M-27.89%219.71M-3.55%189.11M5.86%131.45M35.96%60.9M66.81%304.67M86.50%196.07M64.30%124.18M11.83%44.8M-84.95%182.65M
Total composite income of parent company owners -67.68%19.7M-27.73%219.86M-3.49%189.2M5.50%131.37M35.63%60.94M66.29%304.22M85.92%196.05M63.98%124.52M11.79%44.93M-84.92%182.94M
Total composite income of minority owners -544.59%-256.42K-133.29%-151.17K-547.32%-85.18K125.91%86.6K71.14%-39.78K256.02%454.15K106.01%19.04K4.70%-334.28K-0.37%-137.84K-154.67%-291.09K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------------------Unqualified opinion
Auditor ------------------PwC China (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More